Strandberg Julia 4
4 · Pear Therapeutics, Inc. · Filed Jan 18, 2023
Insider Transaction Report
Form 4
Strandberg Julia
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2023-01-14+33,000→ 41,300 total - Exercise/Conversion
Restricted Stock Units
2023-01-14−33,000→ 67,000 total→ Common Stock (33,000 underlying)
Footnotes (3)
- [F1]Includes 8,300 shares acquired under the Issuer's 2021 Employee Stock Purchase Plan on December 30, 2022.
- [F2]Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
- [F3]The remaining restricted stock units shall vest and settle as to 33% of the shares on January 14, 2024 and 34% on January 14, 2025.